$404 – $533
10 µg, 1×10^6 IFUs
A basic FIV lentivector with a CMV promoter upstream of an MCS—SBI’s MCS2—and puromycin resistance for selection of transductants.
Size: 10 µg (CD110B-1)
Streamline isolation of recombinant AAV particles from media for increased infectivity with AAVanced Concentration Reagent and a simple, one-step protocol.
Sizes: 100 mL (AAV100A-1), 250 mL (AAV110A-1)
Take advantage of AAV-based gene delivery for gene therapy development and other applications with the vector, pAAVK-EF1α-MCS-T2A-mRFP.
Size: 10 µg (AAV528A-1)
Take advantage of AAV-based gene delivery for gene therapy development and other applications with the dual promoter vector, pAAVK-EF1α-MCS-CMV-Puro.
Size: 10 µg (AAV537A-1)